Experts at the meeting agree that: The prescription has an appropriate and precise formulation, reasonable compatibility, drug safety and encouraging efficacy. Its promotion and application have great social benefits! We suggest further large-scale clinical verification and promotion. International communication and industrialized development of the formula (such as the dietary supplements in the U.S.) should be expedited. With this product as the core, an integrated industrial chain of prevention and treatment should be formed to develop and integrate related products, providing a new paradigm for an effective international response to COVID-19.